Russian Journal of Woman and Child Health
ISSN 2618-8430 (Print), 2686-7184 (Online)

Missed miscarriage and hyperprolactinemia. Is there a place for plant-derived medicines?

Google Academy E-library
russian citation index road
ebsco ULRICHS
cyberleninka google-scholar
ВИНИТИ


DOI: 10.32364/2618-8430-2020-3-2-64-69

Missed miscarriage and hyperprolactinemia. Is there a place for plant-derived medicines?

A.A. Olina

D.O. Ott Research Institute of Obstetrics, Gynaecology and Reproduction, St. Petersburg, Russian Federation

Aim: to analyze whether hyperprolactinemia contributes to missed miscarriage and to assess the efficacy of the treatment with plant-derived dopamine agonists.

Patients and Methods: 375 women with anamnestic missed miscarriage before 14 weeks of pregnancy were enrolled. Women with the first and the only missed miscarriage (n=218) were included in group 1. Women with the first and subsequent pregnancies that resulted in intrauterine fetal death (n=157) were included in group 2. The levels of prolactin, thyroid-stimulating hormone (TSH), and thyroid peroxidase antibodies (TPO Abs) were measured. MRI with contrast was performed as needed. Cyclodynon® (1 tablet daily for 3 months) was prescribed for hyperprolactinemia.

Results: elevated prolactin levels were revealed in 45 women (significant differences between group 1 and group 2 were demonstrated). All women with hyperprolactinemia underwent pituitary MRI with contrast. Pituitary microadenoma was identified in 16 w omen (group 1, n=5, 2.3%; group 2, n=11, 7.0%). In a total of 16 women, pituitary adenoma was identified for the first time. Gynecological examination has demonstrated that 20 women are infertile, i.e., 7 women in group 1 (3.2%) and 13 women in group 2 (8.3%). Elevated TSH was revealed in 23 women with missed miscarriage (6.1%), one in two woman (n=13) had hyperprolactinemia. Elevated TPO Abs were revealed in 59 women (15.7%), 17 out of 59 women (28.9%) had hyperprolactinemia, 17 out of 59 women (28.9%) had elevated THS, and 9 out of 59 women (15.3%) had hyperprolactinemia and elevated TSH.

Conclusions: hyperprolactinemia was identified in every ten woman with anamnestic missed miscarriage. Significant differences between women with the only pregnancy loss and women with subsequent pregnancy loss were revealed. 35.6% of women with hyperprolactinemia were diagnosed with microadenoma. Treatment efficacy for both organic and functional hyperprolactinemia was 91.1%.

Keywords: infertility, miscarriage, missed miscarriage, hyperprolactinemia, pituitary microadenoma, dopamine agonist.

For citation: Olina A.A. Missed miscarriage and hyperprolactinemia. Is there a place for plant-derived medicines? Russian Journal of Woman and Child Health. 2020;3(2):64–69. DOI: 10.32364/2618-8430-2020-3-2-64-69.



About the author:

Anna A. Olina — MD, PhD, Professor, 1st Deputy Director, ORCID iD 0000-0001-9101-7569. 

D.O. Ott Research Institute of Obstetrics, Gynaecology and Reproduction. 3, Mendeleevskaya line, St. Petersburg, 199034, Russian Federation.

Contact information: Anna A. Olina, e-mail: olina.otta@mail.ru. Financial Disclosure: author has no a financial or property interest in any material or method mentioned. There is no conflict of interests. Received 24.03.2020.

References
1. The report “Demography 2024. How to ensure sustainable natural population growth in the Russian Federation.” (Electronic resource). URL: https://www.oprf.ru/press/news/2019/newsitem/49521. Access date: 15.03.2020 (in Russ.).
2. Apolikhin O.I., Moskaleva N.G., Komarova V.A. The current demographic situation and the problems of improving the reproductive health of the population of Russia. Experimental and Clinical Urology. 2015;4:4–14 (in Russ.).
3. Gusarov V.M. Statistics: textbook for universities. M.: UNITIDANA; 2002 (in Russ.).
4. Non-developing pregnancy. Guidelines for MARS (Interdisciplinary Association of Reproductive Medicine Specialists). M.: Editorial of StatusPraesens; 2015 (in Russ.).
5. ESHRE guideline: recurrent pregnancy loss Hum Reprod Open. 2018;2018(2):hoy004. DOI: 10.1093/hropen/hoy004.
6. Dzeranova L.K., Bykanova N.S., Pigarova E.A. Hyperprolactinemia and pregnancy: major achievements and unresolved issues. Vestnik reproduktivnogo zdorov’ya. 2011;16–21 (in Russ.).
7. Romantsova T.I. Pregnancy and gender in women with hyperprolactinemia. Trudnyy patsiyent. 2005 (in Russ.).
8. Balan V.E. Possibilities of using herbal preparations in various conditions caused by hyperprolactinemia. Effektivnaya farmakoterapiya. Akusherstvo i ginekologiya. 2007;3:30–35 (in Russ.).
9. Potin V.V., Loginov A.B., Krikheli I.O. The thyroid gland and the reproductive system of women: a manual for doctors. Ed. E.K. Aylamazyan. SPb.; 2008 (in Russ.).
10. Finger M.A., Kvetnoy I.M. Guide to neuroimmunoendocrinology. M.: Medicine; 2008 (in Russ.).
11. Dobrokhotova Yu.E., Sukhikh G.T., Jobava E.M. et al. Hyperhomocysteinemia and folic acid in miscarriage. Rossiyskiy vestnik akushera-ginekologa. 2007;7(5):9–12 (in Russ.).
12. Dobrokhotova Yu.E., Sukhikh G.T., Fayzullin L.Z. et al. The role of hyperhomocysteinemia in the genesis of an undeveloped pregnancy and the onset of miscarriage. RMJ. 2005;13(17):1110–1112 (in Russ.).
13. Maksimova A.V., Pinigina Yu.I., Stroyev Yu.I. et al. Autoimmune thyroiditis Hashimoto, hypothyroidism, prolactin and female reproductive system. Aktual’nyye problemy transportnoy meditsiny. 2011;2(24):122–130 (in Russ.).



License Creative Commons
This work is licensed under a Creative Commons «Attribution» 4.0 License.
Previous article
Next article

Register now and get access to useful services:
  • Загрузка полнотекстовых версий журналов (PDF)
  • Медицинские калькуляторы
  • Список избранных статей по Вашей специальности
  • Видеоконференции и многое другое

С нами уже 50 000 врачей из различных областей.
Присоединяйтесь!

Fatal error: Call to undefined function get_registration_form_description_popup() in /home/c/cb72209/wchjournal/public_html/en/include/reg_form.php on line 89